BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark SD, Kenakin TP, Gertz S, Hassler C, Gay EA, Langston TL, Reinscheid RK, Runyon SP. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation. Neuropharmacology 2017;118:69-78. [PMID: 28267583 DOI: 10.1016/j.neuropharm.2017.03.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Cannella N, Borruto AM, Petrella M, Micioni Di Bonaventura MV, Soverchia L, Cifani C, De Carlo S, Domi E, Ubaldi M. A Role for Neuropeptide S in Alcohol and Cocaine Seeking. Pharmaceuticals 2022;15:800. [DOI: 10.3390/ph15070800] [Reference Citation Analysis]
2 Zarkin A, Jahan R, Uprety R, Zhang Y, McElhinny C, Snyder R, Gay E, Jewula G, Bool H, Clark SD, Runyon S. Identification of a Novel Neuropeptide S Receptor Antagonist Scaffold Based on the SHA-68 Core. Pharmaceuticals (Basel) 2021;14:1024. [PMID: 34681248 DOI: 10.3390/ph14101024] [Reference Citation Analysis]
3 Harris JA, Faust B, Gondin AB, Dämgen MA, Suomivuori C, Veldhuis NA, Cheng Y, Dror RO, Thal DM, Manglik A. Selective G protein signaling driven by Substance P-Neurokinin Receptor structural dynamics.. [DOI: 10.1101/2021.05.16.444192] [Reference Citation Analysis]
4 de Santana Souza L, de Siqueira PA, Fernandes A, Silva Martins R, Cussa Kubrusly RC, Paes-de-Carvalho R, Cunha RA, Dos Santos-Rodrigues A, Pandolfo P. Role of Neuropeptide S on Behavioural and Neurochemical Changes of an Animal Model of Attention-Deficit/Hyperactivity Disorder. Neuroscience 2020;448:140-8. [PMID: 32976984 DOI: 10.1016/j.neuroscience.2020.09.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Blough B, Namjoshi O. Small Molecule Neuropeptide S and Melanocortin 4 Receptor Ligands as Potential Treatments for Substance Use Disorders. Handb Exp Pharmacol 2020;258:61-87. [PMID: 31628605 DOI: 10.1007/164_2019_313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zhao P, Qian X, Nie Y, Sun N, Wang Z, Wu J, Wei C, Ma R, Wang Z, Chai G, Li Y. Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition. Front Behav Neurosci 2019;13:138. [PMID: 31293402 DOI: 10.3389/fnbeh.2019.00138] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
7 Zhang ZR, Tao YX. Physiology, pharmacology, and pathophysiology of neuropeptide S receptor. Prog Mol Biol Transl Sci 2019;161:125-48. [PMID: 30711025 DOI: 10.1016/bs.pmbts.2018.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ruzza C, Ferrari F, Guerrini R, Marzola E, Preti D, Reinscheid RK, Calo G. Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies. Pharmacol Res Perspect 2018;6:e00445. [PMID: 30534379 DOI: 10.1002/prp2.445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Grund T, Neumann ID. Brain neuropeptide S: via GPCR activation to a powerful neuromodulator of socio-emotional behaviors. Cell Tissue Res 2019;375:123-32. [PMID: 30112573 DOI: 10.1007/s00441-018-2902-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sartori SB, Singewald N. New pharmacological strategies for augmenting extinction learning in anxiety disorders. e-Neuroforum 2017;23:A145-A156. [DOI: 10.1515/nf-2017-a011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Sartori SB, Singewald N. Neue pharmakologische Strategien zur Augmentation von Extinktionslernen in der Angsttherapie. e-Neuroforum 2017;23:197-211. [DOI: 10.1515/nf-2017-0011] [Reference Citation Analysis]
12 Grund T, Goyon S, Li Y, Eliava M, Liu H, Charlet A, Grinevich V, Neumann ID. Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis. J Neurosci 2017;37:12214-25. [PMID: 29118105 DOI: 10.1523/JNEUROSCI.2161-17.2017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
13 Grund T, Neumann ID. Neuropeptide S Induces Acute Anxiolysis by Phospholipase C-Dependent Signaling within the Medial Amygdala. Neuropsychopharmacology 2018;43:1156-63. [PMID: 28805209 DOI: 10.1038/npp.2017.169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]